CroíValve develops medical device solutions focused on treating tricuspid regurgitation.
CroíValve has raised $20.0M in total funding. The most recent round was Series B. The last funding was announced in June 2026.
CroíValve's investors include Enterprise Ireland, European Innovation Council, Business Growth Fund, Elkstone Capital Partners, SOSV.
CroíValve is headquartered in Dublin, Ireland.
CroíValve develops medical device solutions focused on treating tricuspid regurgitation.
CroíValve is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CroíValve — Funding & Investors." VCBacked, June 23, 2026, https://www.vcbacked.co/company/crovalve. Accessed July 19, 2026.
VCBacked. (2026). CroíValve — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/crovalve
{{cite web |title=CroíValve — Funding & Investors |url=https://www.vcbacked.co/company/crovalve |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated